Clare Ozawa

Clare Ozawa, listed as board member, appears in our data through filings on Oyster Point Pharma, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 4 November 2019 to 3 January 2023, the count stands at 44 filings.

On the open market, the record shows 2 purchases worth €8.1M and 4 sales worth €7.0M. Purchases outweigh sales by €1.0M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 3 share grants.

The latest filing, published on 4 January 2023, reports a transaction in Oyster Point Pharma, Inc. The most recent open-market purchase was published on 4 November 2019, 2,545 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.